Carl Zeiss Aktie - Fundamentalanalyse - Dividendenrendite KGV

Carl Zeiss Meditec (ISIN: DE0005313704, WKN: 531370) Kursdatum: 19.06.2018 Kurs: 59,900 EUR
Beschreibung Daten
Symbol AFX.DE
Marktkapitalisierung 6.179.303.424,00 USD
Land Deutschland
Indizes HDAXTecDAX
Sektor Gesundheitswesen
Rohdaten nach IFRS in Millionen EUR
Letztes Bilanz Update 02.01.2018


Fundamental Verhältnisse errechnet am: 19.06.2018
25,08 12,04 0,92% 8,65 74,86 38,15 4,50 4,41


Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; and products for surgical treatment of tumors or vascular diseases, such as aneurysms. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Die Finanzoo GmbH übernimmt keine Haftung für die Richtigkeit der Angaben! Alle Angaben sind ohne Gewähr. Quellen:,,